Applying comparative effectiveness research methods in bipolar disorders

Journal of Affective Disorders

Volumn 130, Issue 1-2, 2011, Pages 145-154

  McCombs, Jeffrey S ^a   Ganapathy, Vaidyanathan ^a   Zolfaghari, Sara ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bipolar disorders; Compliance; Treatment costs

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ARTICLE; BIPOLAR DISORDER; CLINICAL RESEARCH; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; DRUG EFFICACY; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPYRETICS; BIPOLAR DISORDER; CHILD; COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953211488     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.09.020     Document Type: Article

References (23)

1. I.S. Al-Zakwani, J.J. Barron, and M.F. Bullano Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications Curr. Med. Res. Opin. 19 7 2003 619 626 (Pubitemid 37288069)
2. American Psychiatric Association Practice guideline for the treatment of patients with bipolar disorder (revision) Am. J. Psychiatry 159 4 Suppl 2002 1 50
3. M. Berk, and L. Berk Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events Ann. Clin. Psychiatry 15 3-4 2003 217 224 (Pubitemid 38176341)
4. Y. Jing, E. Kim, and M. You Healthcare costs associated with treatment of bipolar disorder using a moodstabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone J. Med. Econ. 12 2 2009 104 113
5. P.E. Keck Jr., S.L. McElroy, S.M. Strakowski, S.P. Stanton, D.L. Kizer, T.M. Balistreri, J.A. Bennett, K.C. Tugrul, and S.A. West Factors associated with pharmacologic noncompliance in patients with mania J. Clin. Psychiatry 57 7 1996 292 297 (Pubitemid 26251108)
6. P.E. Keck Jr., S.L. McElroy, S.M. Strakowski, M.L. Bourne, and S.A. West Compliance with maintenance treatment in bipolar disorder Psychopharmacol. Bull. 33 1 1997 87 91 (Pubitemid 27184199)
7. J. Li, J.S. McCombs, and G.L. Stimmel Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program J. Affect. Disord. 71 1-3 2002 131 139
8. K. Rajagopalan, and F.D. Gianfrancesco Compliance with atypical or typical antipsychotics in patients with schizophrenia Poster presented at the Congress on Schizophrenia Research and the Annual Meeting of the American Psychiatric Association 2005
9. K.L. Rascati, M.T. Johnsrud, M.L. Crismon, M.J. Lage, and B. Barber Olanzapine versus risperidone in the treatment of schizophrenia: a comparison of costs among Texas Medicaid patients Pharmacoeconomics 21 10 2003 683 697 (Pubitemid 36920634)
10. P.R. Rosenbaum, and D.B. Rubin The centra role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
11. G.S. Sachs, F. Grossman, S.N. Ghaemi, A. Okamoto, and C.L. Bowden Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety Am. J. Psychiatry 159 7 2002 1146 1154 (Pubitemid 34743254)
12. S. Schneeweiss, A.R. Patrick, and T. Sturmer Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results Med. Care 45 10, suppl 2 2007 S131 S142
13. J. Scott, and M. Pope Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization Am. J. Psychiatry 159 11 2002 1927 1929 (Pubitemid 35283261)
14. M. Tohen, T.G. Jacobs, S.L. Grundy, S.L. McElroy, M.C. Banov, P.G. Janicak, T. Sanger, R. Risser, F. Zhang, V. Toma, J. Francis, G.D. Tollefson, and A. Breier Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group Arch. Gen. Psychiatry 57 9 2000 841 849
15. M. Tohen, R.W. Baker, L.L. Altshuler, C.A. Zarate, T. Suppes, T.A. Ketter, D.R. Milton, R. Risser, J.A. Gilmore, A. Breier, and G.A. Tollefson Olanzapine versus divalproex in the treatment of acute mania Am. J. Psychiatry 159 6 2002 1011 1017 (Pubitemid 34586948)
16. E. Vieta, M. Reinares, B. Corbella, A. Benabarre, I. Gilaberte, F. Colom, A. Martínez-Arán, C. Gastó, and M. Tohen Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder J. Clin. Psychopharmacol. 21 5 2001 469 473 (Pubitemid 32937427)
17. E. Vieta, M. Herraiz, A. Fernández, C. Gastó, A. Benabarre, F. Colom, A. Martínez-Arán, and M. Reinares Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD) J. Clin. Psychiatry 62 8 2001 623 630 (Pubitemid 32848167)
18. H.R. Vikram, J. Buenconsejo, and R. Hasbun Impact of value surgery on 6-month mortality in adults with uncomplicated, left-sided native valve endocarditis: a propensity analysis JAMA 290 24 2003 3207 3214 (Pubitemid 38020682)
19. P.J. Weiden, C. Kozma, A. Grogg, and J. Locklear Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia Psychiatr. Serv. 55 8 2004 886 891 (Pubitemid 39025215)
20. R.D. Weiss, S.F. Greenfield, L.M. Najavits, J.A. Soto, D. Wyner, M. Tohen, and M.L. Griffin Medication compliance among patients with bipolar disorder and substance use disorder J. Clin. Psychiatry 59 4 1998 172 174 (Pubitemid 28208331)
21. H. White A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity Econometrica 48 1980 817 838
22. Z. Zhao, S.L. Tunis, and M.J. Lage Medication treatment patterns following initiation on olanzapine versus risperidone: a retrospective analysis Clin. Drug Invest. 22 11 2002 741 749 (Pubitemid 35388184)
23. B. Zhu, P.M. Kulkarni, M.D. Stensland, and H. Ascher-Svanum Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder Curr. Med. Res. Opin. 23 11 2007 2805 2814 (Pubitemid 350146418)